{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:24:30Z","timestamp":1764995070592,"version":"3.46.0"},"reference-count":25,"publisher":"Japanese Society of Internal Medicine","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,12,1]]},"DOI":"10.2169\/internalmedicine.5609-25","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T18:07:13Z","timestamp":1748455633000},"page":"3387-3394","source":"Crossref","is-referenced-by-count":1,"title":["Methotrexate-Associated Lymphoproliferative Disorder Presenting as Obstructive Jaundice Due to Pancreatic Involvement"],"prefix":"10.2169","volume":"64","author":[{"given":"Yasuhiro","family":"Okuda","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Graduate School of Biomedical &amp; Health Sciences, Hiroshima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Graduate School of Biomedical &amp; Health Sciences, Hiroshima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutaka","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Graduate School of Biomedical &amp; Health Sciences, Hiroshima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Tatsukawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Graduate School of Biomedical &amp; Health Sciences, Hiroshima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juri","family":"Ikemoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Graduate School of Biomedical &amp; Health Sciences, Hiroshima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayaka","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Graduate School of Biomedical &amp; Health Sciences, Hiroshima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Furukawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Graduate School of Biomedical &amp; Health Sciences, Hiroshima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Graduate School of Biomedical &amp; Health Sciences, Hiroshima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriaki","family":"Iijima","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Graduate School of Biomedical &amp; Health Sciences, Hiroshima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risa","family":"Nomura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Graduate School of Biomedical &amp; Health Sciences, Hiroshima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsumi","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Ichinohe","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Oka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Graduate School of Biomedical &amp; Health Sciences, Hiroshima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Tokuhira M, Tamaru JI, Kizaki M. Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders. J Clin Exp Hematop 59: 72-92, 2019.","DOI":"10.3960\/jslrt.19007"},{"key":"2","unstructured":"2. Ellman MH, Hurwitz H, Thomas C, Kozloff M. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol 18: 1741-1743, 1991."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Hashimoto A, Chiba N, Tsuno H, et al. Incidence of malignancy and the risk of lymphoma in Japanese patients with rheumatoid arthritis compared to the general population. J Rheumatol 42: 564-571, 2015.","DOI":"10.3899\/jrheum.140533"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Yamanaka H, Tanaka E, Nakajima A, et al. A large observational cohort study of rheumatoid arthritis, IORRA: providing context for today&apos;s treatment options. Mod Rheumatol 30: 1-6, 2020.","DOI":"10.1080\/14397595.2019.1660028"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Anderson LA, Gadalla S, Morton LM, et al. Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer 125: 398-405, 2009.","DOI":"10.1002\/ijc.24287"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Baecklund E, Iliadou A, Askling J, et al. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 54: 692-701, 2006.","DOI":"10.1002\/art.21675"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Shibusawa M, Kidoguchi K, Tanimoto T. Chapter 4. Other iatrogenic immunodeficiency-associated lymphoproliferative disorders. In: Lymphoma [Internet]. Gallamini A, Juweid M, Eds. Exon Publications, Brisbane (AU), 2021. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK578255\/","DOI":"10.36255\/exon-publications.lymphoma.2021.oil-lpd"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ichikawa A, Arakawa F, Kiyasu J, et al. Methotrexate\/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression. Eur J Haematol 91: 20-28, 2013.","DOI":"10.1111\/ejh.12116"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kurita D, Miyoshi H, Ichikawa A, et al. Methotrexate-associated lymphoproliferative disorders in patients with rheumatoid arthritis: clinicopathologic features and prognostic factors. Am J Surg Pathol 43: 869-884, 2019.","DOI":"10.1097\/PAS.0000000000001271"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin&apos;s lymphomas. Part 1: gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol 8: 727-737, 1997.","DOI":"10.1023\/A:1008282818705"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Boni L, Benevento A, Dionigi G, Cabrini L, Dionigi R. Primary pancreatic lymphoma. Surg Endosc 16: 1107-1108, 2002.","DOI":"10.1007\/s00464-001-4247-1"},{"key":"12","unstructured":"12. Eda A, Okamoto S, Hujinuma A, et al. [A Case of Methotrexate-Associated Lymphoproliferative Disorder Presenting as a Pancreatic Lesion]. Tochigiken Rinsho Eisei Kensa Gishikai Zasshi (J Tochigi Soc Med Technol) 16: 94-97, 2022 (in Japanese)."},{"key":"13","doi-asserted-by":"crossref","first-page":"e346","DOI":"10.1002\/deo2.346","volume":"4","author":"K Kitagawa","year":"2024","unstructured":"13. Kitagawa K, Oyama M, Asada S, et al. Methotrexate-associated lymphoproliferative disorder: a rare pancreatic tumor diagnosed via endoscopic ultrasound-guided fine-needle biopsy. DEN Open 4: e346, 2024.","journal-title":"DEN Open","ISSN":"https:\/\/id.crossref.org\/issn\/2692-4609","issn-type":"print"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Boninsegna E, Zamboni GA, Facchinelli D, et al. CT imaging of primary pancreatic lymphoma: experience from three referral centres for pancreatic diseases. Insights Imaging 9: 17-24, 2018.","DOI":"10.1007\/s13244-017-0585-y"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ramesh J, Hebert-Magee S, Kim H, Trevino J, Varadarajulu S. Frequency of occurrence and characteristics of primary pancreatic lymphoma during endoscopic ultrasound guided fine needle aspiration: a retrospective study. Dig Liver Dis 46: 470-473, 2014.","DOI":"10.1016\/j.dld.2013.12.016"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Wang J, Zhou Y, Liu H, Zhou J, Li X. <sup>18<\/sup>F-FDG PET\/CT assists the diagnosis of primary pancreatic lymphoma: two case reports and literature review. Front Med (Lausanne) 11: 1370762, 2024.","DOI":"10.3389\/fmed.2024.1370762"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Notohara K, Nakamura K. Tissue processing of endoscopic ultrasound-guided fine-needle aspiration specimens from solid pancreatic lesions. J Med Ultrason (2001) 51: 261-274, 2024.","DOI":"10.1007\/s10396-023-01387-8"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Carrara S, Rahal D, Khalaf K, et al. Diagnostic accuracy and safety of EUS-guided end-cutting fine-needle biopsy needles for tissue sampling of abdominal and mediastinal lymphadenopathies: a prospective multicenter series. Gastrointest Endosc 98: 191-198, 2023.","DOI":"10.1016\/j.gie.2023.03.018"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Facciorusso A, Crin\u00f2 SF, Gkolfakis P, et al. Endoscopic ultrasound fine needle biopsy vs fine-needle aspiration for lymph nodes tissue acquisition: a systematic review and meta-analysis. Gastroenterol Rep (Oxf) 10: goac062, 2022.","DOI":"10.1093\/gastro\/goac062"},{"key":"20","unstructured":"20. Inokuma S, Oide T, Tsuda N, et al. Lymphoproliferative disorders related to methotrexate use in rheumatoid arthritis. Clin Rheumatol Rel Res 35: 234-237, 2023 (in Japanese)."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Takanashi S, Aisa Y, Ito C, et al. Clinical characteristics of methotrexate-associated lymphoproliferative disorders: relationship between absolute lymphocyte count recovery and spontaneous regression. Rheumatol Int 37: 1629-1633, 2017.","DOI":"10.1007\/s00296-017-3764-8"},{"key":"22","unstructured":"22. Hoshida Y, Xu JX, Fujita S, et al. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol 34: 322-331, 2007."},{"key":"23","unstructured":"23. Caccamo D, Pervez NK, Marchevsky A. Primary lymphoma of the liver in the acquired immunodeficiency syndrome. Arch Pathol Lab Med 110: 553-555, 1986."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Salloum E, Cooper DL, Howe G, et al. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Rheum 14: 1943-1949, 1996.","DOI":"10.1200\/JCO.1996.14.6.1943"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Katsuyama T, Sada KE, Yan M, et al. Prognostic factors of methotrexate-associate lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents. Mod Rheumatol 27: 773-777, 2017.","DOI":"10.1080\/14397595.2016.1259714"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/23\/64_5609-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T03:28:01Z","timestamp":1764991681000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/23\/64_5609-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":25,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5609-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"article-number":"5609-25"}}